Breakthrough trial aims to ditch damaging steroids for lupus patients
NCT ID NCT04702256
Summary
This major Phase 3 trial is testing if a new drug combination can effectively treat lupus nephritis (a serious kidney complication of lupus) without needing high doses of oral steroids. The study will compare the standard steroid-based treatment against a new regimen using a drug called obinutuzumab, aiming to control the disease while avoiding the severe side effects steroids can cause. About 196 adults and teens with active lupus kidney disease will participate to see if the steroid-free approach works just as well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Internal medicine, Cochin hospital, APHP
RECRUITINGParis, 75014, France
Contact
Conditions
Explore the condition pages connected to this study.